Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan oral solution in pediatric and adolescent hypertension
CTR20243381Phase 3Active
- Sponsor
- Shandong New Era Pharmaceutical
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan in essential hypertension, sponsored by Shandong New Era Pharmaceutical. Started Feb 2025; status: active.
02
Drugs
valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20243381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243381.